Unturned free no download4/10/2023 ![]() ![]() We note that the latest move will add strength to Agilent’s portfolio of biopharma solutions. It enables ECD and other modes of electron-induced fragmentation in MS. Moreover, the technology is designed for mass spectrometers (MS). Notably, the ExD cell helps in accelerating biopharma development as it provides comprehensive, precise and detailed structural information about complex biomolecules by breaking the chemical bonds between these molecules. This is evident from its latest announcement regarding the acquisition of e-Msion, which is known for an innovative electron capture dissociation (ECD) technology called the ExD cell. ![]() Agilent Technologies ( A Quick Quote A - Free Report) is leaving no stone unturned to bolster its portfolio strength on the back of strategic acquisitions.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |